Enhanced maintenance of pregnancy using leukaemia inhibitory factor in embryo culturing
Patent Number: 5366888
Date of First Priority Issue: Monday July 9th, 1990
Date Issued: Tuesday November 22nd, 1994
Assignee: Amrad Corporation Limited (AU)
Inventors: Fry, Richard C. (Altona North, AU); Parr, Ronald A. (Hoppers Crossing, AU)
From Class: Use
Comments: No comments
This patent is assigned to Amrad, a company whose patents have recently been used to challenge the WARF patents. The current patent involves the use of LIF in enhancing ability of implanted embryos to develop into normal offspring. The relevance of this patent to embryonic stem cells is that LIF has been used consistently for generation of embryonic stem cells from a variety of species. The actual role of LIF is believed, in part, to maintain the cells in an undifferentiated state.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.